Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimopoulos

Showing results (121-130 of 3,501) with videos related to

Pageof 351
Sort By:
Current Opinion in Infectious Diseases|February 6, 2016
Duration of therapy of ventilator-associated pneumoniaGeorge Dimopoulos, Dimitrios K Matthaiou
Nature Communications|February 7, 2025
Anopheles gambiae phagocytic hemocytes promote Plasmodium falciparum infection by regulating midgut epithelial integrityVictor Cardoso-Jaime, George Dimopoulos
The Medical Journal of Australia|June 5, 2024
Gender CARE beyond the courts: an alternative framework for resolving disputes over gender health care for children and adolescentsGeorgina Dimopoulos, Michelle Taylor-Sands
Ophthalmic Plastic and Reconstructive Surgery|October 4, 2023
Tendon-Sparing Extraocular Muscle Enlargement Associated With Chronic Inflammatory Demyelinating PolyradiculoneuropathyAntonios D Dimopoulos, Anne Barmettler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Myeloma bone disease: pathophysiology and managementE Terpos, M-A Dimopoulos
Blood Reviews|December 4, 2010
Lenalidomide: an update on evidence from clinical trialsMeletios-Athanassios Dimopoulos, Evangelos Terpos
Expert Opinion on Investigational Drugs|February 16, 2005
Thalidomide and immunomodulatory drugs in the treatment of cancerAristotle Bamias, Meletios A Dimopoulos
Journal of the American College of Cardiology|August 7, 2007
The effect of drug-eluting stents on collateral coronary flowCarlo di Mario, Konstantinos Dimopoulos
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
The role of novel drugs in multiple myelomaM A Dimopoulos, E Kastritis
Leukemia & Lymphoma|November 17, 2006
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?Meletios A Dimopoulos, Efstathios Kastritis
Pageof 351

Showing results (121-130 of 3,501) with videos related to

Sort By:
Pageof 351
Current Opinion in Infectious Diseases|February 6, 2016
Duration of therapy of ventilator-associated pneumoniaGeorge Dimopoulos, Dimitrios K Matthaiou
Nature Communications|February 7, 2025
Anopheles gambiae phagocytic hemocytes promote Plasmodium falciparum infection by regulating midgut epithelial integrityVictor Cardoso-Jaime, George Dimopoulos
The Medical Journal of Australia|June 5, 2024
Gender CARE beyond the courts: an alternative framework for resolving disputes over gender health care for children and adolescentsGeorgina Dimopoulos, Michelle Taylor-Sands
Ophthalmic Plastic and Reconstructive Surgery|October 4, 2023
Tendon-Sparing Extraocular Muscle Enlargement Associated With Chronic Inflammatory Demyelinating PolyradiculoneuropathyAntonios D Dimopoulos, Anne Barmettler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Myeloma bone disease: pathophysiology and managementE Terpos, M-A Dimopoulos
Blood Reviews|December 4, 2010
Lenalidomide: an update on evidence from clinical trialsMeletios-Athanassios Dimopoulos, Evangelos Terpos
Expert Opinion on Investigational Drugs|February 16, 2005
Thalidomide and immunomodulatory drugs in the treatment of cancerAristotle Bamias, Meletios A Dimopoulos
Journal of the American College of Cardiology|August 7, 2007
The effect of drug-eluting stents on collateral coronary flowCarlo di Mario, Konstantinos Dimopoulos
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
The role of novel drugs in multiple myelomaM A Dimopoulos, E Kastritis
Leukemia & Lymphoma|November 17, 2006
Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?Meletios A Dimopoulos, Efstathios Kastritis
Pageof 351